SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040153
Filing Date
2023-08-09
Accepted
2023-08-09 08:01:50
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-20230630.htm   iXBRL 10-Q 2328051
2 EX-31.1 pmvp-ex31_1.htm EX-31.1 22504
3 EX-31.2 pmvp-ex31_2.htm EX-31.2 22473
4 EX-32.1 pmvp-ex32_1.htm EX-32.1 11801
5 EX-32.2 pmvp-ex32_2.htm EX-32.2 12395
  Complete submission text file 0000950170-23-040153.txt   8393515

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pmvp-20230630_def.xml EX-101.DEF 128614
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pmvp-20230630_pre.xml EX-101.PRE 279754
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pmvp-20230630.xsd EX-101.SCH 47885
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pmvp-20230630_lab.xml EX-101.LAB 400093
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pmvp-20230630_cal.xml EX-101.CAL 41186
57 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20230630_htm.xml XML 1726426
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 231153433
SIC: 2834 Pharmaceutical Preparations